These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3622303)

  • 1. Calcium modulation and clinical effect. Profile of cyclandelate.
    Timmerman H
    Drugs; 1987; 33 Suppl 2():1-4. PubMed ID: 3622303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cyclandelate on in vitro red blood cell deformability.
    Hall DW; van den Hoven WE
    Drugs; 1987; 33 Suppl 2():30-40. PubMed ID: 3622306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate.
    Timmerman H
    Br J Clin Pract Suppl; 1984; 34():10-9. PubMed ID: 6430317
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclandelate: calcium modulation and clinical effects. Proceedings of a symposium. Helsinki, 14-15 November, 1986.
    Drugs; 1987; 33 Suppl 2():1-141. PubMed ID: 3622302
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of cyclandelate on Ca++ translocation in human platelets.
    Akkerman JW; van den Hoven WE
    Drugs; 1987; 33 Suppl 2():53-9. PubMed ID: 3622308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human platelet functions by cyclandelate.
    van den Hoven WE; Hall DW
    Drugs; 1987; 33 Suppl 2():41-52. PubMed ID: 3304954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclandelate on prostacyclin release and cytosolic free calcium concentrations in human endothelial cells.
    van Hinsbergh VW
    Drugs; 1987; 33 Suppl 2():60-6. PubMed ID: 3304955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human platelet aggregation by cyclandelate.
    Van den Hoven WE; Hall DW
    Br J Clin Pract Suppl; 1984; 34():34-8. PubMed ID: 6430321
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclandelate as a calcium modulating agent in rat cerebral cortex.
    Bast A; Leurs R; Timmerman H
    Drugs; 1987; 33 Suppl 2():67-74. PubMed ID: 3040372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of cyclandelate vaso-active properties by the measure of the ear-retina time in the rabbit (author's transl)].
    Andermann C; Andermann G; Ehinger C
    Ann Pharm Fr; 1980; 38(3):253-60. PubMed ID: 7425477
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative effect of cyclandelate and papaverine on the cerebral circulation of the rabbit].
    Dumery JP
    Nouv Presse Med; 1976 Oct; 5(32):2081. PubMed ID: 980735
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclandelate and a number of its metabolites inhibit discocyte-echinocyte transformations of human erythrocytes.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():26-30. PubMed ID: 6430318
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory action of cyclandelate and a number of its metabolites on cyclic AMP phosphodiesterase.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():20-5. PubMed ID: 6331483
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits of cyclandelate in the treatment of disorders of ageing.
    Le Poncin-Lafitte M
    Br J Clin Pract Suppl; 1984; 34():58-61. PubMed ID: 6430325
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of cyclandelate on cholesterol synthesis.
    Middleton B; Middleton A; Miciak A; Edwards E; Whitten B; Bell GD; White DA
    Br J Clin Pract Suppl; 1984; 34():43-50. PubMed ID: 6430323
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclandelate. An inhibitor of cholesterol esterification.
    Middleton B; Cacciaguerra F; White D
    Drugs; 1987; 33 Suppl 2():75-9. PubMed ID: 3622309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():31-3. PubMed ID: 6430320
    [No Abstract]   [Full Text] [Related]  

  • 18. A pilot study to evaluate the effect of acute and long-term administration of cyclandelate on the vigilance of subjects submitted to hypoxic conditions. Preliminary report.
    Schaffler K; Hörmann E; Arnold H
    Arzneimittelforschung; 1981; 31(6):1032-5. PubMed ID: 7196236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulatory effect of several cerebral circulatory drugs in man, with special reference to aminophylline, papaverine, cyclandelate, vincamine, prostaglandin E1 and isoxsuprine.
    Miyazaki M
    Jpn Circ J; 1978 Apr; 42(4):433-40. PubMed ID: 702768
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of cyclandelate on dementia.
    Westreich G; Alter M; Lundgren S
    Stroke; 1975; 6(5):535-8. PubMed ID: 1101457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.